<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(8)</volume><submitter>Coltro G</submitter><funding>Associazione Italiana per la Ricerca sul Cancro</funding><funding>Ministero della Salute</funding><journal>Blood cancer journal</journal><pagination>116</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9374751</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis.</pubmed_title><pmcid>PMC9374751</pmcid><funding_grant_id>21267</funding_grant_id><funding_grant_id>NET-2018-12365935</funding_grant_id><pubmed_authors>Pancani F</pubmed_authors><pubmed_authors>Rotunno G</pubmed_authors><pubmed_authors>Loscocco GG</pubmed_authors><pubmed_authors>Vannucchi AM</pubmed_authors><pubmed_authors>Guglielmelli P</pubmed_authors><pubmed_authors>Atanasio A</pubmed_authors><pubmed_authors>Maccari C</pubmed_authors><pubmed_authors>Coltro G</pubmed_authors><pubmed_authors>Mannelli F</pubmed_authors><pubmed_authors>Mannarelli C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis.</name><description/><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-04T10:29:53.784Z</modification><creation>2025-04-04T10:29:53.784Z</creation></dates><accession>S-EPMC9374751</accession><cross_references><pubmed>35961958</pubmed><doi>10.1038/s41408-022-00713-6</doi></cross_references></HashMap>